Physician

Pavana Kumari Beerelli, M.D.

According to 2025 Medicare claims, Pavana Beerelli, M.D. (NPI: 1891957031) practices allergy/immunology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF BREVARD LLC (NPI: 1861400103; TIN: 593360315) and primary practice location at 32955-5789. Beerelli is affiliated with the Aledade A2909 FL MSSP Enhanced (ACO ID: A2909), participating under the MSSP model.

Beerelli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 540 traditional Medicare patients, billed 25,966 HCPCS/CPT codes, and received $604,664 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 857 prescription claims across 299 beneficiaries totaling $1,071,783 in drug costs, led by Cuvitru (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 90 claims. Open Payments data shows 125 records totaling $16,090. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $53,989 to $604,664. Similarly, Part D prescription costs have moved sharply higher in recent years, from $52,615 to $1,071,783. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $381 and ending at $1,633.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	98	3,135	$53,989
2016	131	3,169	$55,614
2017	142	4,158	$82,868
2018	145	3,740	$74,636
2019	135	3,832	$87,392
2020	170	4,204	$61,237
2021	347	6,658	$108,407
2022	380	8,121	$142,848
2023	476	12,279	$250,660
2024	540	25,966	$604,664

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	174	$52,615
2016	76	259	$112,008
2017	84	347	$165,336
2018	93	324	$210,865
2019	103	387	$344,249
2020	120	555	$410,461
2021	218	816	$495,899
2022	240	790	$496,333
2023	246	682	$653,335
2024	299	857	$1,071,783

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$49,691
2017	N/R	36	$78,961
2018	N/R	116	$157,876
2019	N/R	75	$97,895
2020	N/R	107	$122,843
2021	N/R	184	$219,086
2022	N/R	178	$282,452
2023	N/R	74	$81,433
2024	N/R	90	$97,382

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	269	269	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	382	623	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	67	70	$56
94010	Test to measure expiratory airflow and volume	76	94	$18
95004	Test for allergy using allergenic extract	56	3,012	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	24	560	$286,179
Xolair	Omalizumab	53	1,484	$148,396
Tezspire	Tezepelumab-Ekko	25	834	$114,648
Cutaquig	Immun Glob G(Igg)-Hipp/Maltose	26	728	$104,613
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	2,430	$49,539

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	16	$39,373
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	11	$29,175
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	11	$21,983
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	16	$5,274
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	18	$1,381

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	125	$16,090	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pavana Kumari Beerelli, M.D.?

Tedicare shows public-source Medicare data for Pavana Kumari Beerelli, M.D. (NPI 1891957031), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pavana Kumari Beerelli, M.D. have ACO affiliation data?

Pavana Kumari Beerelli, M.D. is shown with ACO affiliation data for Aledade A2909 FL MSSP Enhanced (MSSP, ACO ID A2909).

What billing organization is linked to Pavana Kumari Beerelli, M.D.?

Pavana Kumari Beerelli, M.D. is linked to MEDICAL ASSOCIATES OF BREVARD LLC (billing NPI 1861400103) in the available physician profile data.

Does Pavana Kumari Beerelli, M.D. have Open Payments data?

Pavana Kumari Beerelli, M.D. has 125 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.